ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the six research firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average […]

Leave a Reply

Your email address will not be published.

Previous post Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Major Shareholder Purchases $166,214.08 in Stock
Next post The Revolution are hurting after 2-0 loss at Seattle